Abstract
The antimicrobial killing activity toward methicillin-resistant Staphylococcus aureus (MRSA) has been a serious emerging global issue. New effective antimicrobials and/or new approaches to settle this issue are urgently needed. The oriental herb, Alpinia officinarum, has been used in Korea for several hundreds of years to treat various infectious diseases. As it is well known, one of the active constituents of Alpinia officinarum is galangin. Against the 17 strains, the minimum inhibitory concentrations (MICs) of galangin (GAL) were in the range of 62.5∼125 μg/ml, and the MICs of gentamicin (GEN) ranged from 1.9 μg/ml to 2,000 μg/ml. The fractional inhibitory concentrations (FICs) of GAL, in combination with GEN, against 3 test strains were 0.4, 3.9, and 250 μg/ml, and were all 15.62 μg/ml in GEN. The FIC index showed marked synergism in the value range of 0.19 to 0.25. By determining time-kill curves, also confirmed the low synergism of the GAL and GEN combination against 4 h, 8 h, 12 h, and 24 h cultured MRSA. The time-kill study results indicated a low synergistic effect against 3 test strains. Thus, the mixture of GAL and GEN could lead to the development of new combination antibiotics against MRSA infection.
Similar content being viewed by others
References
An, N., Z.M. Zou, Z. Tian, X.Z. Luo, S.L. Yang, and L.Z. Xu. 2008. Diarylheptanoids from the rhizomes of Alpiniaofficinarum and their anticancer activity. Fitoterapia 79, 27–31.
Barrett, F.F., R.F. McGehee, and M. Finland. 1968. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N. Engl. J. Med. 279, 441–448.
Capasso, R. and N. Mascolo. 2003. Inhibitory effect of the plant flavonoid galangin on rat vas deferens in vitro. Life Sci. 72, 2993–3001.
Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard 7th ed. Document M7-A7. Clinical and Laboratory Standards Institute, Villanova, Pa, USA.
Cushnie, T.P. and A.J. Lamb. 2006. Assessment of the antibacterial activity of galangin against 4-quinolone resistant strains of Staphylococcus aureus. Phytomedicine 13, 187–191.
Dawis, M.A., H.D. Isenberg, K.A. France, and S.G. Jenkins. 2003. In vitro activity of gatifloxacin alone and incombination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms. J. Antimicrob. Chemother. 51, 1203–1211.
Denny, B.J., P.A. Lambert, and P.W. West. 2002. The flavonoid galangin inhibits the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia. FEMS Microbiol. Lett. 208, 21–24.
Drobbin, M.T., S.T. Phelan, and P.J. Antonelli. 2007. Dexamethasone does not alter in vitro antibacterial efficacy of gentamicin. Otolaryngol. Head Neck Surg. 136, 769–772.
Eliopoulos, G.M. and C.T. Eliopoulos. 1988. Antibiotic combinations: should they be tested?. Clin. Microbiol. Rev. 1, 139–156.
Guadalupe, M.N., E.L. Blanca, V.P. Mariano, and S.S. Fortino. 2006. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains. Ann. Clin. Microbiol. Antimicrob. 5, 25.
Heo, M.Y., S.J. Sihn, and W.W. Au. 2001. Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat. Res. 488, 135–150.
Kim, J.K., Y.M. Yoo, H.K. Kim, B.H. Lee, K.S. Oh, H.W. Seo, G.H. Yon, O. Gendaram, D.Y. Kwon, Y.S. Kim, and S.Y. Ryu. 2006. Vasorelaxation effects of the flavonoids from the rhizome extract of Alpinia officinarum Hance on isolated rat thoracic aorta. Kor. J. Pharmacogn. 37, 56–59.
Linton, A.H., A.J. Hedges, and P.M. Bennet. 1988. Monitoring for the development of antimicrobial resistance during the use of olaquindox as a feed additive on commercial pig farms. J. Appl. Bacteriol. 64, 311–327.
Liu, I.X., D.G. Durham, and R.M. Richards. 2000. Baicalin synergy with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus other β-lactam-resistant strains of S. aureus. J. Pharm. Pharmacol. 52, 361–366.
Lowy, F.D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339, 520–532.
Marraro, R.V. and J.L. Mitchell. 1975. Experiences and observations with the typing of Staphylococcus aureus phage 94. J. Clin. Microbiol. 1, 180–184.
Mascaretti, O. 2003. Bacteria versus antibacterial agents: an integrated approach, p. 229–333. ASM Press, Washington, D.C., USA.
Mazumdar, K., N.K. Dutta, K.A. Kumar, and S.G. Dastidar. 2005. In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains. Biol. Pharm. Bull. 28, 713–717.
Nascimento, A.M., M.G. Brandao, G.B. Oliveira, I.C. Fortes, and S.E. Chartone. 2007. Synergistic bactericidal activity of Eremanthus erythropappus oil or beta-bisabolene with ampicillin against Staphylococcus aureus. Antonie Van Leeuwenheok 92, 95–100.
Noble, W.C., Z. Virani, and R.G. Cree. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 72, 195–198.
Parker, M.T. and J.H. Hewitt. 1970. Methicillin resistance in Staphylococcus aureus. Lancet 1, 800–804.
Rountree, P.M. 1978. History of staphylococcal infection in Australia. Med. J. Aust. 2, 543–546.
Sanford, M.D., A.F. Widmer, M.J. Bale, R.N. Jones, and R.P. Wenzel. 1994. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 19, 1123–1128.
Shahverdi, A.R., A. Fakhimi, G. Zarrini, G. Dehghan, and M. Iranshahi. 2007. Galbanic acid from Ferula szowitsiana enhanced the antibacterial activity of penicillin G and cephalexin against Staphylococcus aureus. Biol. Pharm. Bull. 30, 1805–1807.
Shin, D., K. Kinoshita, K. Koyama, and K. Takahashi. 2002. Antiemetic principles of Alpinia officinarum. J. Nat. Prod. 65, 1315–1318.
Silver, L. and K. Bostian. 1990. Screening of natural products for antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 9, 455–461.
Tsuji, B.T. and M.J. Rybak. 2005. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob. Agents Chemother. 49, 2735–2745.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, YS., Kang, OH., Choi, JG. et al. Synergistic effects of the combination of galangin with gentamicin against methicillin-resistant Staphylococcus aureus . J Microbiol. 46, 283–288 (2008). https://doi.org/10.1007/s12275-008-0012-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-008-0012-7